[Employment of a program in the leprosy campaign in Mayotte based on the use of rifampicin and clofazimine].
D002991:Clofazimine / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D006801:Humans; D007195:Indian Ocean Islands; D007538:Isoniazid / Q000627:therapeutic use; D007918:Leprosy / Q000188:drug therapy*; D009166:Mycobacterium leprae / Q000187:drug effects; D012293:Rifampin / Q000627:therapeutic use*
D002991:Clofazimine; D007538:Isoniazid; D012293:Rifampin
Mise en oeuvre d'un programme de lutte contre la lèpre à Mayotte fondé sur l'utilisation de rifampicine et de clofazimine.